Usama Waqar, Christina Gozza, Courtney L Devin, Terrah J Paul Olson, Seth A Rosen
{"title":"Comparison of Outcomes Following Surgery for Diverticulitis Among Immunocompetent and Immunosuppressed Patients.","authors":"Usama Waqar, Christina Gozza, Courtney L Devin, Terrah J Paul Olson, Seth A Rosen","doi":"10.1177/00031348251346532","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundThe prevalence of immunosuppressed (IS) patients is on the rise, posing unique challenges during colectomy for diverticulitis. This study compares outcomes between immunocompetent (IC) and IS patients.MethodsWe identified all patients undergoing surgery for diverticulitis between 2021 and 2022 in the National Surgical Quality Improvement Program. We measured the textbook outcome (TO), defined as absence of prolonged length of stay (LOS), mortality, major morbidity, readmission, or reoperation within 30 days. Regression analyses were used to compare outcomes between IS and IC groups, stratified by case acuity.ResultsWe identified 16,679 patients, including 1102 (6.6%) IS patients. Immunosuppressed patients were more likely to present with complicated diverticulitis and preoperative sepsis and more often required urgent or emergent surgery, open surgery, or diversion. Textbook outcome was achieved less often in IS patients (37.2% vs 61.5%), and they had higher rates of major morbidity (37.7% vs 19.5%) (<i>P</i> < 0.001). On regression, IS patients undergoing elective surgery were less likely to achieve TO (OR 0.668 [95% CI 0.538-0.830]) and more likely to experience major morbidity (1.356 [1.065-1.726]), prolonged LOS, sepsis, or readmission. In the urgent setting, IS was associated with higher odds of major morbidity (1.595 [1.072-2.372]), readmission (1.877 [1.160-3.037]), and mortality (3.149 [1.549-6.402]). In the emergency setting, IS patients had increased odds of reoperation (1.566 [1.035-2.370]) and mortality (1.545 [1.033-2.310]).ConclusionEmergent or urgent surgery is associated with higher mortality in IS patients compared to IC patients. In the elective setting, IS patients have similar mortality but lower TO achievement and higher morbidity.</p>","PeriodicalId":7782,"journal":{"name":"American Surgeon","volume":" ","pages":"1093-1100"},"PeriodicalIF":0.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00031348251346532","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundThe prevalence of immunosuppressed (IS) patients is on the rise, posing unique challenges during colectomy for diverticulitis. This study compares outcomes between immunocompetent (IC) and IS patients.MethodsWe identified all patients undergoing surgery for diverticulitis between 2021 and 2022 in the National Surgical Quality Improvement Program. We measured the textbook outcome (TO), defined as absence of prolonged length of stay (LOS), mortality, major morbidity, readmission, or reoperation within 30 days. Regression analyses were used to compare outcomes between IS and IC groups, stratified by case acuity.ResultsWe identified 16,679 patients, including 1102 (6.6%) IS patients. Immunosuppressed patients were more likely to present with complicated diverticulitis and preoperative sepsis and more often required urgent or emergent surgery, open surgery, or diversion. Textbook outcome was achieved less often in IS patients (37.2% vs 61.5%), and they had higher rates of major morbidity (37.7% vs 19.5%) (P < 0.001). On regression, IS patients undergoing elective surgery were less likely to achieve TO (OR 0.668 [95% CI 0.538-0.830]) and more likely to experience major morbidity (1.356 [1.065-1.726]), prolonged LOS, sepsis, or readmission. In the urgent setting, IS was associated with higher odds of major morbidity (1.595 [1.072-2.372]), readmission (1.877 [1.160-3.037]), and mortality (3.149 [1.549-6.402]). In the emergency setting, IS patients had increased odds of reoperation (1.566 [1.035-2.370]) and mortality (1.545 [1.033-2.310]).ConclusionEmergent or urgent surgery is associated with higher mortality in IS patients compared to IC patients. In the elective setting, IS patients have similar mortality but lower TO achievement and higher morbidity.
免疫抑制(IS)患者的患病率正在上升,这给憩室炎结肠切除术带来了独特的挑战。这项研究比较了免疫功能正常(IC)和免疫功能正常(IS)患者的预后。方法:我们在国家手术质量改进计划中确定了2021年至2022年期间接受憩室炎手术的所有患者。我们测量了标准预后(TO),定义为30天内无延长住院时间(LOS)、死亡率、主要发病率、再入院或再手术。采用回归分析比较IS组和IC组之间的结果,并按病例视力分层。结果共纳入16679例患者,其中1102例(6.6%)为IS患者。免疫抑制的患者更有可能出现复杂的憩室炎和术前败血症,更经常需要紧急或紧急手术、开放手术或转移。IS患者达到教科书结局的频率较低(37.2% vs 61.5%),其主要发病率较高(37.7% vs 19.5%) (P < 0.001)。在回归分析中,接受择期手术的IS患者实现to的可能性较小(OR为0.668 [95% CI 0.538-0.830]),更有可能出现严重发病率(OR为1.356[1.065-1.726])、延长的LOS、败血症或再入院。在紧急情况下,IS与较高的主要发病率(1.595[1.072-2.372])、再入院(1.877[1.160-3.037])和死亡率(3.149[1.549-6.402])相关。在急诊情况下,IS患者的再手术率(1.566[1.035-2.370])和死亡率(1.545[1.033-2.310])均增加。结论与IC患者相比,急诊或紧急手术与is患者更高的死亡率相关。在选择性情况下,IS患者的死亡率相似,但较低的TO成就和较高的发病率。
期刊介绍:
The American Surgeon is a monthly peer-reviewed publication published by the Southeastern Surgical Congress. Its area of concentration is clinical general surgery, as defined by the content areas of the American Board of Surgery: alimentary tract (including bariatric surgery), abdomen and its contents, breast, skin and soft tissue, endocrine system, solid organ transplantation, pediatric surgery, surgical critical care, surgical oncology (including head and neck surgery), trauma and emergency surgery, and vascular surgery.